182 related articles for article (PubMed ID: 19895612)
21. Supernumerary isochromosome 1, idic(1)(p12), leading to tetrasomy 1q in Burkitt lymphoma.
Roug AS; Wendtland P; Bendix K; Kjeldsen E
Cytogenet Genome Res; 2014; 142(1):7-13. PubMed ID: 24217199
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples.
Maria Murga Penas E; Schilling G; Behrmann P; Klokow M; Vettorazzi E; Bokemeyer C; Dierlamm J
Genes Chromosomes Cancer; 2014 Jun; 53(6):497-515. PubMed ID: 24590883
[TBL] [Abstract][Full Text] [Related]
23. Application of 2016 WHO classification in the diagnosis of paediatric high-grade
Zhang L; Brown LE; Bowen LM; McCarthy LC; Cooley LD; Repnikova E; Gener MA; Garola R; August KJ; Hays JA; Zwick DL; Li W
J Clin Pathol; 2020 Sep; 73(9):563-570. PubMed ID: 31964683
[TBL] [Abstract][Full Text] [Related]
24. The 11q-Gain/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma With 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS.
Grygalewicz B; Woroniecka R; Rymkiewicz G; Rygier J; Borkowska K; Kotyl A; Blachnio K; Bystydzienski Z; Nowakowska B; Pienkowska-Grela B
Am J Clin Pathol; 2017 Dec; 149(1):17-28. PubMed ID: 29272887
[TBL] [Abstract][Full Text] [Related]
25. Molecular cytogenetic analysis in splenic lymphoma with villous lymphocytes: frequent allelic imbalance of the RB1 gene but not the D13S25 locus on chromosome 13q14.
García-Marco JA; Nouel A; Navarro B; Matutes E; Oscier D; Price CM; Catovsky D
Cancer Res; 1998 Apr; 58(8):1736-40. PubMed ID: 9563492
[TBL] [Abstract][Full Text] [Related]
26. A high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemia.
Hernández JA; Rodríguez AE; González M; Benito R; Fontanillo C; Sandoval V; Romero M; Martín-Núñez G; de Coca AG; Fisac R; Galende J; Recio I; Ortuño F; García JL; de las Rivas J; Gutiérrez NC; San Miguel JF; Hernández JM
Haematologica; 2009 Mar; 94(3):364-71. PubMed ID: 19252174
[TBL] [Abstract][Full Text] [Related]
27. Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myeloma.
Kaufmann H; Krömer E; Nösslinger T; Weltermann A; Ackermann J; Reisner R; Bernhart M; Drach J
Eur J Haematol; 2003 Sep; 71(3):179-83. PubMed ID: 12930318
[TBL] [Abstract][Full Text] [Related]
28. A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia.
Van Dyke DL; Shanafelt TD; Call TG; Zent CS; Smoley SA; Rabe KG; Schwager SM; Sonbert JC; Slager SL; Kay NE
Br J Haematol; 2010 Feb; 148(4):544-50. PubMed ID: 19895615
[TBL] [Abstract][Full Text] [Related]
29. Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations.
Aukema SM; Theil L; Rohde M; Bauer B; Bradtke J; Burkhardt B; Bonn BR; Claviez A; Gattenlöhner S; Makarova O; Nagel I; Oschlies I; Pott C; Szczepanowski M; Traulsen A; Kluin PM; Klapper W; Siebert R; Murga Penas EM
Br J Haematol; 2015 Sep; 170(6):814-25. PubMed ID: 26104998
[TBL] [Abstract][Full Text] [Related]
30. Frequent chromosome arm 13q deletion in aggressive non-Hodgkin's lymphoma.
Wada M; Okamura T; Okada M; Teramura M; Masuda M; Motoji T; Mizoguchi H
Leukemia; 1999 May; 13(5):792-8. PubMed ID: 10374885
[TBL] [Abstract][Full Text] [Related]
31. Chromosomal aberrations evaluated by CGH, FISH and GTG-banding in a case of AIDS-related Burkitt's lymphoma.
Zunino A; Viaggi S; Ottaggio L; Fronza G; Schenone A; Roncella S; Abbondandolo A
Haematologica; 2000 Mar; 85(3):250-5. PubMed ID: 10702812
[TBL] [Abstract][Full Text] [Related]
32. The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab.
Forero-Castro M; Robledo C; Lumbreras E; Benito R; Hernández-Sánchez JM; Hernández-Sánchez M; García JL; Corchete-Sánchez LA; Tormo M; Barba P; Menárguez J; Ribera J; Grande C; Escoda L; Olivier C; Carrillo E; García de Coca A; Ribera JM; Hernández-Rivas JM
Br J Haematol; 2016 Feb; 172(3):428-38. PubMed ID: 26567765
[TBL] [Abstract][Full Text] [Related]
33. 13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancer.
Kluth M; Scherzai S; Büschek F; Fraune C; Möller K; Höflmayer D; Minner S; Göbel C; Möller-Koop C; Hinsch A; Neubauer E; Tsourlakis MC; Sauter G; Heinzer H; Graefen M; Wilczak W; Luebke AM; Burandt E; Steurer S; Schlomm T; Simon R
Genes Chromosomes Cancer; 2018 Oct; 57(10):504-512. PubMed ID: 29923647
[TBL] [Abstract][Full Text] [Related]
34. Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study.
Bigoni R; Cuneo A; Roberti MG; Bardi A; Rigolin GM; Piva N; Scapoli G; Spanedda R; Negrini M; Bullrich F; Veronese ML; Croce CM; Castoldi G
Leukemia; 1997 Nov; 11(11):1933-40. PubMed ID: 9369429
[TBL] [Abstract][Full Text] [Related]
35. Application of interphase fluorescence in situ Hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas.
Siebert R; Matthiesen P; Harder S; Zhang Y; Borowski A; Zühlke-Jenisch R; Metzke S; Joos S; Weber-Matthiesen K; Grote W; Schlegelberger B
Blood; 1998 Feb; 91(3):984-90. PubMed ID: 9446660
[TBL] [Abstract][Full Text] [Related]
36. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization.
Zojer N; Königsberg R; Ackermann J; Fritz E; Dallinger S; Krömer E; Kaufmann H; Riedl L; Gisslinger H; Schreiber S; Heinz R; Ludwig H; Huber H; Drach J
Blood; 2000 Mar; 95(6):1925-30. PubMed ID: 10706856
[TBL] [Abstract][Full Text] [Related]
37. Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel.
Reddy KS
Br J Haematol; 2006 Mar; 132(6):705-22. PubMed ID: 16487171
[TBL] [Abstract][Full Text] [Related]
38. Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance.
Königsberg R; Ackermann J; Kaufmann H; Zojer N; Urbauer E; Krömer E; Jäger U; Gisslinger H; Schreiber S; Heinz R; Ludwig H; Huber H; Drach J
Leukemia; 2000 Nov; 14(11):1975-9. PubMed ID: 11069034
[TBL] [Abstract][Full Text] [Related]
39. Detection of myc translocations in lymphoma cells by fluorescence in situ hybridization with yeast artificial chromosomes.
Veronese ML; Ohta M; Finan J; Nowell PC; Croce CM
Blood; 1995 Apr; 85(8):2132-8. PubMed ID: 7718884
[TBL] [Abstract][Full Text] [Related]
40. Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation.
Kröger N; Schilling G; Einsele H; Liebisch P; Shimoni A; Nagler A; Perez-Simon JA; San Miguel JF; Kiehl M; Fauser A; Schwerdtfeger R; Wandt H; Sayer HG; Myint H; Klingemann H; Zabelina T; Dierlamm J; Hinke A; Zander AR
Blood; 2004 Jun; 103(11):4056-61. PubMed ID: 14982868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
